New 917 Ti-Touch Coulometer

New 917 Ti-Touch Coulometer

Chemistry & Biochemistry / Pharmaceutical Industries

October 08, 2015

Metrohm is pleased to announce that the successful Ti-Touch titrator family has been expanded by a new member, the 917 Ti-Touch Coulometer.

Just like its siblings, the 917 Coulometer is a compact, stand-alone instrument integrating control unit, magnetic stirrer, and the pump for reagent exchange into a single, space-saving design. Outstanding features and benefits make the 917 Coulometer the preferred solution for routine use in any laboratory.

Maximum user safety
•    Integral pump:  Reagent exchange at the push of a button prevents contact with Karl Fischer reagent at all times
•    Crucial parameters (number of determinations, reagent capacity, drift ….  are monitored at all times


Maximum ease of use
•    Automated transfer of the sample weight
•    Each user can start his or her favorite applications (up to 14!) at a single  tap on the color touchscreen
•    Titration starts automatically after sample has been added


Even more convenience
•    Paperless reports can be generated and saved at the USB port  to a flash drive  or to a network drive
•    Ethernet interface: export results to your LIMS and manage them there!
•    Thermal sample preparation (manual or automated with the 885 Compact Oven Sample Changer)

New CryoMed™ Controlled-Rate Freezer

New CryoMed™ Controlled-Rate Freezer

Chemistry & Biochemistry / Pharmaceutical Industri...

Thermo Scientific™ is pleased to announce the launch of the CryoMed™controlled-rate freezer ideal for customers in research, cell and gene therapy, vaccine production, and biobanking that need repeatable freezing capabilities at a controlled rate.

January 15, 2021 More +
Simple new prenatal blood test for early and accurate detection of major chromosomal abnormalities

Simple new prenatal blood test for early and accurate detection of major chromosomal abnormalities

Chemistry & Biochemistry / Pharmaceutical Industri...

Multiplicom is proud to launch Clarigo™, a new CE-IVD1 non-invasive prenatal test (NIPT). This highly accurate blood test will enable genetic analysis laboratories to detect the presence or absence of major chromosomal abnormalities such as trisomy 21 (Down’s syndrome), 18 (Edwards’ syndrome) and 13 (Patau syndrome), in the fetus, as early as in the first trimester of pregnancy by analysis of the fetus’s DNA in the maternal blood.

October 22, 2015 More +
Ready to make an enquiry Call us on: + 961 1 39 66 77
Or email us